Pulsed Radiofrequency of Shoulder Individual Nerves Versus Brachial Plexus in Management of Chronic Post Mastectomy Shoulder Pain
Launched by CAIRO UNIVERSITY · Jun 3, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods to help manage shoulder pain that some people experience after having breast surgery (mastectomy). The study will compare a treatment called pulsed radiofrequency applied to individual nerves in the shoulder against pulsed radiofrequency applied to a larger group of nerves known as the brachial plexus. The goal is to see which method is more effective in relieving pain for patients who are still suffering despite taking maximum doses of pain medication like tramadol.
To participate in the trial, you need to be between 18 and 65 years old, have been diagnosed with shoulder pain after a mastectomy, and have a body mass index (BMI) between 20 and 40. If you qualify and choose to take part, you can expect to receive one of the two treatments and be monitored for how well it works in reducing your pain. It’s important to note that some people may not be eligible, such as those who are pregnant or have certain health conditions. If you’re interested, this could be a chance to find relief from persistent pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age (18-65) Years.
- • American Society of Anesthesiologists (ASA) physical status (II- III).
- • Patients with post mastectomy shoulder pain.
- • Body mass index (BMI): (20-40) kg/m2.
- • Patients on maximum daily dose tramadol ( 450mg ) and still in pain
- Exclusion Criteria:
- • Patient refusal.
- • Known sensitivity or contraindication to drugs used in the study.
- • Pregnancy.
- • Recent myocardial infarction.
- • Hemodynamically unstable.
- • Local and systemic sepsis.
- • Psychiatric illness.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported